Randomized trial demonstrates improved outcomes in cancer treatments using seamless designs, suggesting faster patient access to therapies.
Seamless designs and master protocols have the potential to improve confirmatory clinical trials. In the disease area of cancer, this ultimately means that patients can receive life-saving treatments sooner.
No takes yet. Share an insight, caveat, or question.
Burdon et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: